ARTICLE | Company News
Radius in-licenses Eisai's SERMs
June 30, 2006 12:36 AM UTC
Eisai (Tokyo:4523; Osaka:4523) granted Radius ( Cambridge, Mass.) an exclusive worldwide license to develop and commercialize selective estrogen receptor modulators (SERMs). Eisai retains rights in Ja...